DEC 07, 2017 07:39 AM PST
Antibody Drug Conjugates BOC Sciences
POSTED BY: Alice Green
2 1 17


This is shared by BOC Sciences (www.bocsci.com).
Antibody-drug conjugates (ADCs) are a very important class of highly potent drugs designed as a targeted therapy for the treatment of people who has cancer. It represents an innovative therapeutic application that includes the unique, high specificity and antitumor activity of monoclonal antibodies which are tumor-specific but not very cytotoxic, with the cell killing activity of small molecule drugs that are too toxic to be used on their own. Scientists could optimize the features of both components by linking monoclonal antibodies with cytotoxic agents.

Loading Comments...
Search